. Author manuscript; available in PMC: 2011 Jul 1.

Published in final edited form as: J Mol Cell Cardiol. 2010 Mar 29;49(1):25–32. doi: 10.1016/j.yjmcc.2010.03.013

Table 1.

Average time to first SCaW

Treatment	Ave. Time to 1^st SCaW (sec)	n Active (total)	% Active which were paced at ≥ 0.5 Hz
Control, non- failing	n/a	0 (44)	n/a
ISO	3.29 ± 0.51	18 (46)	78%
ISO + KN93	17.6 ± 8.2	7 (46)	100%
ISO + KN92	4.31 ± 0.74	20 (35)	75%
ISO + H89	2.15 ± 0.33	24 (46)	92%
Forskolin	8.59 ± 4.14	7 (27)	86%
HF	4.1 ± 0.25	3 (26)	67%
HF + ISO	3.83 ± 0.74	19 (26)	84%
HF + ISO + KN93	18.65 ± 8.18	3 (28)	100%
HF + ISO + H89	7.43 ± 3.92	9 (17)	89%
HF + Forskolin	1.97 ± 0.28	9 (18)	89%